Parallax Volatility Advisers, L.P. Cerus Corp Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.83 $118,009 - $200,581	34,405 Added 244.01%	48,505 $175,000
Q2 2022 Aug 15, 2022	BUY	$4.41 - $5.69 $62,181 - $80,229	14,100 New	14,100 $75,000
Q2 2021 Aug 16, 2021	SELL	$5.35 - $6.35 $20,929 - $24,841	-3,912 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$5.68 - $7.87 $22,220 - $30,787	3,912 New	3,912 $24,000
Q1 2018 May 15, 2018	SELL	$3.56 - $5.74 $55,920 - $90,163	-15,708 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.76 - $3.95 $43,354 - $62,046	15,708	15,708 $53,000

156

148M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.